Zobrazeno 1 - 10
of 567
pro vyhledávání: '"Jordan J Feld"'
Autor:
Zoë R Greenwald, Jordan J Feld, Dan Werb, Peter C Austin, Samantha Drover, Daniel Fridman, Ahmed Bayoumi, Tara Gomes, Claire E Kendall, Lauren Lapointe-Shaw, Ayden I Scheim, Sofia R Bartlett, Eric I Benchimol, Zachary Bouck, Christina Greenaway, Naveed Z Janjua, Pamela Leece, William WL Wong, Beate Sander, Jeffrey C Kwong
Publikováno v:
International Journal of Population Data Science, Vol 9, Iss 5 (2024)
Objective Health administrative data can support population-level research among people who inject drugs (PWID), however these data sources remain underutilized due to the difficulty in identifying drug use in routinely collected data. We validated c
Externí odkaz:
https://doaj.org/article/0d1bc83c8a704ef6805e9b51e5bd4cdf
Autor:
Nicole S Erler, Robert J de Knegt, Jordan J Feld, Bettina E Hansen, Harry L A Janssen, Adriaan J van der Meer, Christoph Welsch, Stefan Zeuzem, Amy Puenpatom, Thomas Vanwolleghem, Robert A de Man, Lisette A P Krassenburg, Raoel Maan, Stijn van Hees, Orlando Cerrhoci, Johannes Vermehren
Publikováno v:
BMJ Open Gastroenterology, Vol 10, Iss 1 (2023)
Background and aims Historical paired liver biopsy studies are likely to underestimate current progression of disease in patients with chronic hepatitis C virus (HCV) infection. We aimed to assess liver disease progression according to the non-invasi
Externí odkaz:
https://doaj.org/article/20684bd7459a42a999c55f58c9c6cca6
Autor:
Alicia Vachon, Elizabeth Giles, Nishi Patel, Alexandra Presbitero, Muhammad Atif Zahoor, Carla S. Coffin, Jordan J Feld, Curtis L. Cooper, Carla Osiowy
Publikováno v:
Journal of Clinical Virology Plus, Vol 2, Iss 4, Pp 100126- (2022)
Background: Over 296 million people worldwide are living with chronic Hepatitis B (CHB) infection who require monitoring of viral activity and disease progression. Serum HBV RNA is a promising new biomarker in CHB management. No standardized method f
Externí odkaz:
https://doaj.org/article/37ed952c865c4611bf60dd6b2ba1a9c5
Autor:
Morven Cunningham, Marco Iafolla, Yada Kanjanapan, Orlando Cerocchi, Marcus Butler, Lillian L Siu, Philippe L Bedard, Kendra Ross, Bettina Hansen, Anna Spreafico, Jordan J Feld
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253070 (2021)
Background and aimsImmune checkpoint inhibitors (ICI) are increasingly used in cancer therapy. Elevated liver enzymes frequently occur in patients treated with ICI but evaluation is poorly described. We sought to better understand causes of liver enz
Externí odkaz:
https://doaj.org/article/7836004569814b22aad22e6c8e90288a
Autor:
Lauren Lapointe-Shaw, Firass Georgie, David Carlone, Orlando Cerocchi, Hannah Chung, Yvonne Dewit, Jordan J Feld, Laura Holder, Jeffrey C Kwong, Beate Sander, Jennifer A Flemming
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0201120 (2018)
BACKGROUND:To evaluate screening and treatment strategies, large-scale real-world data on liver disease-related outcomes are needed. We sought to validate health administrative data for identification of cirrhosis, decompensated cirrhosis and hepatoc
Externí odkaz:
https://doaj.org/article/30764cf0dd0a41bab8265eb914e888f3
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0191184 (2018)
BACKGROUND:Hepatitis C virus (HCV) is the most burdensome infectious illness in Canada. Current screening strategies miss a significant proportion of cases, leaving many undiagnosed. Elevated HCV prevalence in those born between 1945 and 1965 has pro
Externí odkaz:
https://doaj.org/article/2b7099cc9b36408e9522a908d3cab48b
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 29, Iss 1, Pp 19-34 (2015)
Chronic hepatitis C remains a significant medical and economic burden in Canada, affecting nearly 1% of the population. Since the last Canadian consensus conference on the management of chronic hepatitis C, major advances have occurred that warrant a
Externí odkaz:
https://doaj.org/article/6c3b86ba24824beb9661e89b485226f2
Autor:
Sonya A MacParland, Marc Bilodeau, Jason Grebely, Julie Bruneau, Curtis Cooper, Marina Klein, Selena M Sagan, Norma Choucha, Louise Balfour, Frank Bialystok, Mel Krajden, Jennifer Raven, Eve Roberts, Rodney Russell, Michael Houghton, D Lorne Tyrrell, Jordan J Feld
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 28, Iss 9, Pp 481-487 (2014)
Hepatitis C virus (HCV) currently infects approximately 250,000 individuals in Canada and causes more years of life lost than any other infectious disease in the country. In August 2011, new therapies were approved by Health Canada that have achieved
Externí odkaz:
https://doaj.org/article/2476bb3e96734802921ca6a8e3bc7b10
Autor:
Jason Grebely, Marc Bilodeau, Jordan J Feld, Julie Bruneau, Benedikt Fischer, Jennifer F Raven, Eve Roberts, Norma Choucha, Rob P Myers, Selena M Sagan, Joyce A Wilson, Frank Bialystok, D Lorne Tyrrell, Michael Houghton, Mel Krajden, on behalf of the National CIHR Research Training Program in Hepatitis C
Publikováno v:
Canadian Journal of Gastroenterology, Vol 27, Iss 11, Pp 627-632 (2013)
In Canada, hepatitis C virus (HCV) infection results in considerable morbidity, mortality and health-related costs. Within the next three to 10 years, it is expected that tolerable, short-duration (12 to 24 weeks) therapies capable of curing >90% of
Externí odkaz:
https://doaj.org/article/57253eb307e94ad1b36afc858508d059
Publikováno v:
Canadian Journal of Gastroenterology, Vol 26, Iss 6, Pp 359-375 (2012)
Chronic hepatitis C remains a significant medical and economic burden in Canada, affecting nearly 1% of the population. Since the last consensus conference on the management of chronic hepatitis C, major advances have warranted a review of recommende
Externí odkaz:
https://doaj.org/article/f6a65b6003d848cea111554a4cb2ee22